Patient-reported outcomes during and after treatment for locally advanced rectal cancer in the PROSPECT trial (Alliance N1048)

E Basch, AC Dueck, SA Mitchell, H Mamon… - Journal of Clinical …, 2023 - ascopubs.org
PURPOSE The standard of care for locally advanced rectal cancer in North America is
neoadjuvant pelvic chemoradiation with fluorouracil (5FUCRT). Neoadjuvant chemotherapy …
被引用次数：53 相关文章

Patient-Reported Outcomes during and after Treatment for Locally Advanced Rectal Cancer in the PROSPECT Trial (Alliance N1048)

E Basch, AC Dueck, SA Mitchell… - Journal of Clinical …, 2023 - mayoclinic.elsevierpure.com
PURPOSEThe standard of care for locally advanced rectal cancer in North America is
neoadjuvant pelvic chemoradiation with fluorouracil (5FUCRT). Neoadjuvant chemotherapy …

Patient-Reported Outcomes during and after Treatment for Locally Advanced Rectal Cancer in the PROSPECT Trial (Alliance N1048)

E Basch, AC Dueck, SA Mitchell… - Journal of …, 2023 - mdanderson.elsevierpure.com
PURPOSEThe standard of care for locally advanced rectal cancer in North America is
neoadjuvant pelvic chemoradiation with fluorouracil (5FUCRT). Neoadjuvant chemotherapy …

Patient-Reported Outcomes During and After Treatment for Locally Advanced Rectal Cancer in the PROSPECT Trial (Alliance N1048).

E Basch, AC Dueck, SA Mitchell, H Mamon… - Journal of Clinical …, 2023 - europepmc.org
Purpose The standard of care for locally advanced rectal cancer in North America is
neoadjuvant pelvic chemoradiation with fluorouracil (5FUCRT). Neoadjuvant chemotherapy …

Patient-Reported Outcomes During and After Treatment for Locally Advanced Rectal Cancer in the PROSPECT Trial (Alliance N1048)

E Basch, AC Dueck, SA Mitchell… - Journal of Clinical …, 2023 - ingentaconnect.com
PURPOSE The standard of care for locally advanced rectal cancer in North America is
neoadjuvant pelvic chemoradiation with fluorouracil (5FUCRT). Neoadjuvant chemotherapy …

Patient-Reported Outcomes During and After Treatment for Locally Advanced Rectal Cancer in the PROSPECT Trial (Alliance N1048)

E Basch, AC Dueck, SA Mitchell, H Mamon, M Weiser… - 2023 - pubmed.ncbi.nlm.nih.gov
Purpose The standard of care for locally advanced rectal cancer in North America is
neoadjuvant pelvic chemoradiation with fluorouracil (5FUCRT). Neoadjuvant chemotherapy …